Star Equity (STRR) Competitors $1.95 0.00 (0.00%) As of 07/3/2025 01:36 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock STRR vs. BDMD, FEMY, VVOS, PETV, RVP, NXGL, ALUR, CLGN, NRXS, and PSTVShould you be buying Star Equity stock or one of its competitors? The main competitors of Star Equity include Baird Medical Investment (BDMD), Femasys (FEMY), Vivos Therapeutics (VVOS), PetVivo (PETV), Retractable Technologies (RVP), NexGel (NXGL), Allurion Technologies (ALUR), CollPlant Biotechnologies (CLGN), NeurAxis (NRXS), and Plus Therapeutics (PSTV). These companies are all part of the "medical equipment" industry. Star Equity vs. Its Competitors Baird Medical Investment Femasys Vivos Therapeutics PetVivo Retractable Technologies NexGel Allurion Technologies CollPlant Biotechnologies NeurAxis Plus Therapeutics Star Equity (NASDAQ:STRR) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, valuation and risk. Do institutionals and insiders have more ownership in STRR or BDMD? 3.8% of Star Equity shares are held by institutional investors. Comparatively, 19.8% of Baird Medical Investment shares are held by institutional investors. 33.5% of Star Equity shares are held by insiders. Comparatively, 78.9% of Baird Medical Investment shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility and risk, STRR or BDMD? Star Equity has a beta of 0.93, indicating that its stock price is 7% less volatile than the S&P 500. Comparatively, Baird Medical Investment has a beta of -0.94, indicating that its stock price is 194% less volatile than the S&P 500. Does the media refer more to STRR or BDMD? In the previous week, Baird Medical Investment had 1 more articles in the media than Star Equity. MarketBeat recorded 1 mentions for Baird Medical Investment and 0 mentions for Star Equity. Star Equity's average media sentiment score of 0.00 beat Baird Medical Investment's score of -0.63 indicating that Star Equity is being referred to more favorably in the media. Company Overall Sentiment Star Equity Neutral Baird Medical Investment Negative Is STRR or BDMD more profitable? Baird Medical Investment has a net margin of 0.00% compared to Star Equity's net margin of -16.43%. Baird Medical Investment's return on equity of 0.00% beat Star Equity's return on equity.Company Net Margins Return on Equity Return on Assets Star Equity-16.43% -8.24% -3.48% Baird Medical Investment N/A N/A N/A Do analysts rate STRR or BDMD? Star Equity currently has a consensus target price of $5.00, suggesting a potential upside of 156.41%. Given Star Equity's stronger consensus rating and higher probable upside, equities research analysts clearly believe Star Equity is more favorable than Baird Medical Investment.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Star Equity 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Baird Medical Investment 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger valuation & earnings, STRR or BDMD? Baird Medical Investment has lower revenue, but higher earnings than Star Equity. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStar Equity$57.17M0.11-$10.44M-$3.43-0.57Baird Medical Investment$37.04M0.70N/AN/AN/A SummaryBaird Medical Investment beats Star Equity on 7 of the 13 factors compared between the two stocks. Get Star Equity News Delivered to You Automatically Sign up to receive the latest news and ratings for STRR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding STRR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STRR vs. The Competition Export to ExcelMetricStar EquityDIVERSIFIED OPS IndustryMulti-Sector SectorNASDAQ ExchangeMarket Cap$6.26M$16.01B$14.70B$9.01BDividend YieldN/A4.39%4.13%4.04%P/E Ratio-0.578.637.3520.30Price / Sales0.114.333.61103.84Price / Cash5.9833.0931.7957.47Price / Book0.182.362.085.68Net Income-$10.44M$951.45M$922.22M$249.13M7 Day Performance-3.47%3.26%2.90%3.30%1 Month Performance-14.85%0.67%-0.14%5.20%1 Year Performance-50.88%-6.43%-4.92%21.38% Star Equity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STRRStar Equity3.604 of 5 stars$1.95flat$5.00+156.4%-50.9%$6.26M$57.17M-0.57460BDMDBaird Medical InvestmentN/A$3.66-6.2%N/AN/A$25.68MN/A0.00N/AGap UpHigh Trading VolumeFEMYFemasys3.7083 of 5 stars$0.97-1.4%$8.67+797.4%-15.1%$25.04M$1.63M-1.0630Gap UpVVOSVivos Therapeutics1.4047 of 5 stars$3.16-3.7%$4.82+52.4%+75.9%$19.32M$15.03M-1.83160PETVPetVivoN/A$0.80+1.3%N/A+65.3%$19.17M$1.05M-1.7820Gap DownHigh Trading VolumeRVPRetractable Technologies2.1359 of 5 stars$0.64+3.1%N/A-43.9%$18.56M$33.75M-1.18240Gap DownNXGLNexGel0.4438 of 5 stars$2.58+7.5%N/A+21.5%$18.37M$8.69M-5.7310Positive NewsALURAllurion Technologies2.887 of 5 stars$2.46+1.2%$22.83+828.2%-92.0%$18.12M$32.11M-0.20501CLGNCollPlant Biotechnologies2.5476 of 5 stars$1.36-1.4%$11.50+745.6%-72.3%$17.55M$2.47M-1.1170NRXSNeurAxis3.3704 of 5 stars$2.42-2.4%$7.00+189.3%-10.5%$17.46M$2.93M-1.3219News CoverageInsider TradePSTVPlus Therapeutics1.7009 of 5 stars$0.35+10.4%$10.83+3,014.8%-80.7%$16.07MN/A-0.1220High Trading Volume Related Companies and Tools Related Companies Baird Medical Investment Competitors Femasys Competitors Vivos Therapeutics Competitors PetVivo Competitors Retractable Technologies Competitors NexGel Competitors Allurion Technologies Competitors CollPlant Biotechnologies Competitors NeurAxis Competitors Plus Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:STRR) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Star Equity Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Star Equity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
